Ekambaram Ilamathi is a Nephrology physician. OpenAlex indexes 7 publications with 254 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
38 S Windsor Ave
Brightwaters, NY 117181505
Telephone
516-318-8527Provider last certified this registry record 12 Jul 2023.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year202518 payments
- Amgen Inc.Program year202510 payments
- Travere Therapeutics, Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
54.7%Beta blocker13.4%Carvedilol79%Metoprolol Succinate21%Part D<11 patientsCalcium channel blocker10.4%Amlodipine Besylate65%Nifedipine Er35%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
21.7%SGLT2 inhibitor10.9%Farxiga57%Jardiance43%Part D<11 patientsVitamin D3 Analog6%Calcitriol100%Part D≥12 patients+ 2 more classes in this area
Blood & clotting
11.3%Factor Xa inhibitor5.7%Eliquis100%Part D<11 patientsSolutions for parenteral nutrition5.5%Calcium Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Normal fractional urate excretion identifies hyponatremic patients with reset osmostat
Journal of Nephrology
2012 - Preliminary findings from the National Pre-ESRD Education Initiative.
PubMed
2000
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”